Credit Suisse AG Grows Position in Integer Holdings Co. (NYSE:ITGR)

Credit Suisse AG raised its position in shares of Integer Holdings Co. (NYSE:ITGR) by 8.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,989 shares of the medical equipment provider’s stock after buying an additional 3,342 shares during the quarter. Credit Suisse AG owned about 0.12% of Integer worth $3,177,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ITGR. Covestor Ltd boosted its holdings in shares of Integer by 420.6% in the 1st quarter. Covestor Ltd now owns 328 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 265 shares during the period. Parallel Advisors LLC purchased a new position in shares of Integer in the 1st quarter worth approximately $29,000. Strs Ohio purchased a new position in shares of Integer in the 1st quarter worth approximately $46,000. State of Wyoming boosted its holdings in shares of Integer by 129.5% in the 4th quarter. State of Wyoming now owns 840 shares of the medical equipment provider’s stock worth $58,000 after purchasing an additional 474 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Integer by 28.5% in the 1st quarter. Tower Research Capital LLC TRC now owns 775 shares of the medical equipment provider’s stock worth $60,000 after purchasing an additional 172 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Insider Transactions at Integer

In other news, Director Jean M. Hobby sold 3,625 shares of the business’s stock in a transaction on Friday, June 9th. The stock was sold at an average price of $83.85, for a total value of $303,956.25. Following the completion of the transaction, the director now directly owns 9,126 shares of the company’s stock, valued at approximately $765,215.10. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.84% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Wells Fargo & Company boosted their price objective on Integer from $87.00 to $94.00 and gave the company an “equal weight” rating in a report on Friday, July 28th. Benchmark boosted their price objective on Integer from $90.00 to $105.00 and gave the company a “buy” rating in a report on Friday, July 28th. StockNews.com assumed coverage on Integer in a report on Thursday, August 17th. They set a “hold” rating for the company. Citigroup assumed coverage on Integer in a report on Thursday, May 11th. They set a “neutral” rating and a $88.00 price objective for the company. Finally, KeyCorp boosted their price objective on Integer from $96.00 to $105.00 and gave the company an “overweight” rating in a report on Friday, July 28th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Integer has a consensus rating of “Hold” and a consensus target price of $93.83.

Integer Trading Down 0.4 %

Shares of NYSE ITGR opened at $85.01 on Friday. The company has a quick ratio of 1.94, a current ratio of 3.08 and a debt-to-equity ratio of 0.68. The business has a fifty day simple moving average of $86.76 and a two-hundred day simple moving average of $81.71. The firm has a market cap of $2.83 billion, a PE ratio of 40.10, a price-to-earnings-growth ratio of 1.56 and a beta of 1.12. Integer Holdings Co. has a twelve month low of $50.05 and a twelve month high of $96.17.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.15. The business had revenue of $400.04 million during the quarter, compared to analyst estimates of $367.05 million. Integer had a return on equity of 9.67% and a net margin of 4.77%. Analysts expect that Integer Holdings Co. will post 4.33 earnings per share for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.